IDA
GILD icon

Intelligence Driven Advisers’s Gilead Sciences GILD Stock Holding History

Intelligence Driven Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
3,280
-1,282
-28% -$169K 0.07% 90
2026
Q1 		$636K Buy
4,562
+1,665
+57% +$233K 0.11% 59
2025
Q4 		$356K Buy
2,897
+476
+20% +$57.8K 0.05% 91
2025
Q3 		$269K Buy
2,421
+186
+8% +$21.1K 0.04% 97
2025
Q2 		$248K Buy
+2,235
New +$238K 0.04% 98

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Intelligence Driven Advisers's GILD Position: Q2 2026 in Review

Intelligence Driven Advisers reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $169K and leaving 3,280 shares worth $414K. The position accounts for 0.07% of the portfolio, ranked #90.

Intelligence Driven Advisers first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $636K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Intelligence Driven Advisers held 3,280 shares of Gilead Sciences worth $414K as of Q2 2026.
  • Intelligence Driven Advisers sold 1,282 Gilead Sciences shares in Q2 2026, an estimated $169K.
  • Gilead Sciences made up 0.07% of Intelligence Driven Advisers's portfolio in Q2 2026, its #90 holding.
  • Intelligence Driven Advisers first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Intelligence Driven Advisers's Gilead Sciences position peaked at $636K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Intelligence Driven Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.